FIL Study on ABVD DD-DI as Upfront Therapy in HL.

Clinical trial NCT03159897 · COMPLETED

Trial details

NCT number: NCT03159897
Sponsor: Fondazione Italiana Linfomi - ETS
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hodgkin Lymphoma

Start date: 2017-08-01
Primary completion: 2021-11-02
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.